Skip to content

Construction of characteristic intestinal microbiota/metabolism map of colorectal cancer liver metastasis and functional mechanism

Construction of characteristic intestinal microbiota/metabolism map of colorectal cancer liver metastasis and functional mechanism

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400079481
Enrollment
Unknown
Registered
2024-01-04
Start date
2023-07-30
Completion date
Unknown
Last updated
2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Colorectal cancer (without any distant metastases):No
Colorectal cancer liver metastasis:No

Sponsors

Shandong University Qilu Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Colorectal cancer patient selection criteria: 1. Age: between 18-80 years old; 2. Pathological diagnosis and imaging diagnosis of colorectal cancer. (2) Colorectal cancer liver metastasis patient selection criteria: 1. Age: between 18-80 years old; 2. Pathological diagnosis and imaging diagnosis of colorectal cancer liver metastasis. (3) Healthy controls patient selection criteria: 1. Be between 18-80 years of age; 2. After routine screening and evaluation, the subject was determined to be healthy, that is, there was no obvious abnormality in blood routine and tumor markers, and no abnormality in HIV, hepatitis B and syphilis results; There were no obvious abnormalities on gastrointestinal endoscopy and imaging.

Exclusion criteria

Exclusion criteria: (1) Exclusion criteria for patients with colorectal cancer with / without distant metastasis are as follows: 1. Patients taking antibiotic medications within 30 days or probiotic products within 14 days; 2. Have undergone any form of treatment (surgery, chemotherapy, radiotherapy, etc.); 3. Individuals with a history of colorectal cancer, irritable bowel syndrome and other coexisting malignancies; 4. The patient has other distant metastases other than the liver; 5. Have autoimmune diseases; 6. Lack of clinical information. (2) Exclusion criteria for healthy controls: 1. Have a personal history of cancer and precancerous lesions, or a first-degree relative in the family has a history of cancer and precancerous lesions; 2. Have suspected clinical signs and symptoms of colorectal cancer 3. People with autoimmune diseases.

Design outcomes

Primary

MeasureTime frame
Gut microbiota;Gut metabolites;Serum metabolites;

Countries

China

Contacts

Public ContactLutao Du

Shandong University Qilu Hospital

dulutao1984@163.com+86 176 6008 5177

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026